Acquihires and Antitrust: When Buying the Team Isn’t Buying the Company
The Federal Trade Commission (FTC) has trained its sights on one of Silicon Valley’s most familiar deal structures: the “acquihire.” In a Bloomberg podcast interview, FTC Chair Andrew Ferguson said the agency plans to scrutinize how acquihires are structured—looking for features that could bring them within merger law and trigger Hart-Scott-Rodino Act (HSR) reporting thresholds. The acting head of the U.S. Justice Department’s (DOJ) Antitrust Division, Omar Assefi, went further, calling acquihires a “red flag” designed to sidestep merger review.
Others share that concern. U.S. Sens. Elizabeth Warren (D-Mass.) and Richard Blumenthal (D-Conn.) recently urged the antitrust agencies to investigate so-called “reverse acquihires,” which they argue evade scrutiny and “risk further consolidating the Big Tech industry.”
Skepticism about regulatory arbitrage makes sense. But in the case of acquihires—and related license-and-hire agreements, where firms license a target’s technology while hiring its staff—the concern looks misplaced. Section 7 of the Clayton Act and Section 1 of the Sherman Act target conduct with meaningful competitive effects. Acquihires rarely clear that bar. They center on talent transfers, which makes their structural impact too fleeting for Section 7 and their competitive harms too speculative for Section 1. As a result, most fall outside enforcement.
That gap reflects design, not defect. When agencies face novel conduct, uncertain harms, and resource-intensive enforcement, the better course often is restraint. Acquihires can serve legitimate ends: enabling entrepreneurial exit, preserving labor mobility, and protecting professional reputations in the tech ecosystem. Treating them as presumptively suspect risks destroying real economic value. It also invites agencies to spend scarce resources on cases that current law is unlikely to support.
This piece proceeds from that premise. Acquihires differ from transactions typically policed by antitrust law because they involve the transfer of talent. That distinction carries important implications, especially in startup ecosystems where such deals play a central role. For now, there is little reason to rethink a doctrine that largely treats them as benign.